Abrdn Healthcare Investor... (HQH)
NYSE: HQH
· Real-Time Price · USD
19.05
0.15 (0.79%)
At close: Oct 15, 2025, 3:59 PM
19.06
0.05%
After-hours: Oct 15, 2025, 05:36 PM EDT
Abrdn Healthcare Investors Income Statement
Financials in USD. Fiscal
year is
October - September.
| Fiscal Year | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 |
| Period Ending | Dec 31, 2024 | Jun 30, 2024 | Dec 31, 2023 | Jun 30, 2023 | Dec 31, 2022 | Jun 30, 2022 | Dec 31, 2021 | Jun 30, 2021 |
Revenue | 5.46M | 5.31M | 4.66M | 5.63M | 4.32M | 3.96M | 3.22M | 3.26M |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 5.46M | 5.31M | 4.66M | 5.63M | 4.32M | 3.96M | 3.22M | 3.26M |
Operating Income | -189.15K | -31.12K | -1.02M | -163.15K | -1.43M | -2.24M | -3.34M | -2.89M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 85.25M | 99.7M | -26.83M | 83.16M | -79.18M | -115.05M | 66.61M | 88.57M |
Net Income | 85.25M | 99.7M | -26.83M | 83.16M | -79.18M | -115.05M | 66.61M | 88.57M |
Selling & General & Admin | 5.65M | 5.34M | 5.69M | 5.79M | 5.75M | 6.19M | 6.55M | 6.16M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 5.65M | 5.34M | 5.69M | 5.79M | 5.75M | 6.19M | 6.55M | 6.16M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 37.76K | 18.63K | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 5.65M | 5.34M | 5.69M | 5.79M | 5.75M | 6.19M | 6.55M | 6.16M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 53.63M | 50.62M | 50.53M | 48.35M | 48.34M | 46.34M | 46.2M | 44.65M |
Shares Outstanding (Diluted) | 53.63M | 50.62M | 50.53M | 48.35M | 48.34M | 46.34M | 46.2M | 44.65M |
EPS (Basic) | 1.59 | 1.97 | -0.53 | 1.72 | -1.64 | -2.48 | 1.44 | 1.98 |
EPS (Diluted) | 1.59 | 1.97 | -0.53 | 1.72 | -1.64 | -2.48 | 1.44 | 1.98 |
EBITDA | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBIT | -189.15K | -31.12K | -1.02M | -163.15K | -1.43M | -2.24M | -3.34M | -2.89M |
Depreciation & Amortization | 189.15K | 31.12K | 1.02M | 163.15K | 1.43M | 2.24M | 3.34M | 2.89M |
Source: Financial Modeling Prep. Financial Sources.